首页> 美国卫生研究院文献>International Journal of Nephrology >Cardiorenal Syndrome Type 4—Cardiovascular Disease in Patients with Chronic Kidney Disease: Epidemiology Pathogenesis and Management
【2h】

Cardiorenal Syndrome Type 4—Cardiovascular Disease in Patients with Chronic Kidney Disease: Epidemiology Pathogenesis and Management

机译:心肾综合征4型—慢性肾脏病患者的心血管疾病:流行病学发病机制和管理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The term cardiorenal syndrome refers to the interaction between the heart and the kidney in disease and encompasses five distinct types according to the initial site affected and the acute or chronic nature of the injury. Type 4, or chronic renocardiac syndrome, involves the features of chronic renal disease (CKD) leading to cardiovascular injury. There is sufficient epidemiologic evidence linking CKD with increased cardiovascular morbidity and mortality. The underlying pathophysiology goes beyond the highly prevalent traditional cardiovascular risk burden affecting renal patients. It involves CKD-related factors, which lead to cardiac and vascular pathology, mainly left ventricular hypertrophy, myocardial fibrosis, and vascular calcification. Risk management should consider both traditional and CKD-related factors, while therapeutic interventions, apart from appearing underutilized, still await further confirmation from large trials.
机译:术语“心脏肾综合征”是指疾病中心脏和肾脏之间的相互作用,根据受影响的最初部位和损伤的急性或慢性性质,它涵盖了五种不同的类型。 4型或慢性肾上腺综合征,涉及导致心血管损伤的慢性肾脏疾病(CKD)的特征。有足够的流行病学证据表明CKD与心血管疾病的发病率和死亡率增加有关。潜在的病理生理学超越了影响肾脏患者的高度普遍的传统心血管风险负担。它涉及与CKD相关的因素,可导致心脏和血管病变,主要是左心室肥大,心肌纤维化和血管钙化。风险管理应同时考虑传统因素和与CKD相关的因素,而治疗性干预措施,尽管未得到充分利用,但仍在等待大型试验的进一步证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号